BIO-Key International Inc BKYI.OQ BKYI.O is expected to show a rise in quarterly revenue when it reports results on March 31 for the period ending December 31 2025
The Holmdel New Jersey-based company is expected to report a 50.5% increase in revenue to $2.2 million from $1.46 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for BIO-Key International Inc is for a loss of 7 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for BIO-Key International Inc is $2.00, about 243.9% above its last closing price of $0.58
This summary was machine generated March 27 at 13:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments